Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,355,317
+$48,537 QoQ
Shares Held
9,274
-1.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
#2,215
of 4,676 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Probity Advisors, Inc. holds $17,628,696 across 10 Drug Manufacturers - General names. JNJ ranks #4 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,714 | $3,255,253 | |
| 2 | ABBV |
AbbVie Inc.
|
12,209 | $3,072,272 | |
| 3 | MRK |
Merck & Co., Inc.
|
19,934 | $2,561,519 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
9,274 | $2,355,317 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,128 | $1,532,251 | |
| 6 | GSK |
GSK plc
|
24,377 | $1,277,842 | |
| 7 | PFE |
Pfizer Inc
|
50,988 | $1,227,791 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
20,006 | $1,152,745 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,355,317 | 9,274 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $2,306,780 | 9,437 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,039,285 | 9,854 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,869,589 | 10,083 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,550,870 | 10,153 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,682,280 | 10,144 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,509,977 | 10,441 | Shares | Sole | 2025-03-05 | |
| 2024-09-30 | $1,735,176 | 10,707 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $1,538,772 | 10,528 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,663,051 | 10,513 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,629,625 | 10,397 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,673,066 | 10,742 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,766,429 | 10,672 | Shares | Sole | 2023-08-10 | |
| 2022-12-31 | $1,984,662 | 11,235 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,871,615 | 11,457 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,164,911 | 12,196 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,244,086 | 12,662 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,261,203 | 13,218 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,168,460 | 13,427 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $2,160,565 | 13,115 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,126,195 | 12,937 | Shares | Sole | 2021-04-28 | |
| 2020-09-30 | $1,972,213 | 13,247 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,876,988 | 13,347 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,725,539 | 13,159 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||